Sea Mild Biotechnology Co., Ltd.
Sea Mild Biotechnology Co., Ltd. manufactures and sells paints, coatings, and detergents in Taiwan. It offers laundry, household, and personal detergent, as well as epidemic prevention products under the Sea Mild Biotech brand name. The company was established in 2007 is headquartered in Taoyuan City, Taiwan.
Market Cap & Net Worth: Sea Mild Biotechnology Co., Ltd. (7516)
Sea Mild Biotechnology Co., Ltd. (TWO:7516) has a market capitalization of $5.43 Million (NT$179.57 Million) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #32078 globally and #1875 in its home market, demonstrating a -2.82% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sea Mild Biotechnology Co., Ltd.'s stock price NT$9.30 by its total outstanding shares 19308900 (19.31 Million).
Sea Mild Biotechnology Co., Ltd. Market Cap History: 2026 to 2026
Sea Mild Biotechnology Co., Ltd.'s market capitalization history from 2026 to 2026. Data shows growth from $5.43 Million to $5.43 Million (0.00% CAGR).
Sea Mild Biotechnology Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sea Mild Biotechnology Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 7516 by Market Capitalization
Companies near Sea Mild Biotechnology Co., Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to Sea Mild Biotechnology Co., Ltd. by market ranking:
- Procter & Gamble Company (NYSE:PG): Ranked #35 globally with a market cap of $351.41 Billion USD.
- Unilever PLC (PINK:UNLYF): Ranked #141 globally with a market cap of $131.81 Billion USD.
- UNILEVER PLC LS -,035 (XETRA:UNV0): Ranked #147 globally with a market cap of $126.11 Billion USD ( €122.86 Billion EUR).
- L'Oréal S.A (PINK:LRLCF): Ranked #215 globally with a market cap of $94.58 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #35 | Procter & Gamble Company | NYSE:PG | $351.41 Billion | $151.48 |
| #141 | Unilever PLC | PINK:UNLYF | $131.81 Billion | $60.96 |
| #147 | UNILEVER PLC LS -,035 | XETRA:UNV0 | $126.11 Billion | €56.81 |
| #215 | L'Oréal S.A | PINK:LRLCF | $94.58 Billion | $368.10 |
Sea Mild Biotechnology Co., Ltd. Historical Marketcap From 2026 to 2026
Between 2026 and today, Sea Mild Biotechnology Co., Ltd.'s market cap moved from $5.43 Million to $ 5.43 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$5.43 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Sea Mild Biotechnology Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.43 Million USD |
| MoneyControl | $5.43 Million USD |
| MarketWatch | $5.43 Million USD |
| marketcap.company | $5.43 Million USD |
| Reuters | $5.43 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.